Anti-RNF19A monoclonal antibody

Pre-made anti-RNF19A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RNF19A/RNF19A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1522-Ab-1/ GM-Tg-hg-IP1522-Ab-2Anti-Human RNF19A monoclonal antibodyHuman
GM-Tg-rg-IP1522-Ab-1/ GM-Tg-rg-IP1522-Ab-2Anti-Rat RNF19A monoclonal antibodyRat
GM-Tg-mg-IP1522-Ab-1/ GM-Tg-mg-IP1522-Ab-2Anti-Mouse RNF19A monoclonal antibodyMouse
GM-Tg-cynog-IP1522-Ab-1/ GM-Tg-cynog-IP1522-Ab-2Anti-Cynomolgus/ Rhesus macaque RNF19A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1522-Ab-1/ GM-Tg-felg-IP1522-Ab-2Anti-Feline RNF19A monoclonal antibodyFeline
GM-Tg-cang-IP1522-Ab-1/ GM-Tg-cang-IP1522-Ab-2Anti-Canine RNF19A monoclonal antibodyCanine
GM-Tg-bovg-IP1522-Ab-1/ GM-Tg-bovg-IP1522-Ab-2Anti-Bovine RNF19A monoclonal antibodyBovine
GM-Tg-equg-IP1522-Ab-1/ GM-Tg-equg-IP1522-Ab-2Anti-Equine RNF19A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1522-Ab-1/ GM-Tg-hg-IP1522-Ab-2; GM-Tg-rg-IP1522-Ab-1/ GM-Tg-rg-IP1522-Ab-2;
GM-Tg-mg-IP1522-Ab-1/ GM-Tg-mg-IP1522-Ab-2; GM-Tg-cynog-IP1522-Ab-1/ GM-Tg-cynog-IP1522-Ab-2;
GM-Tg-felg-IP1522-Ab-1/ GM-Tg-felg-IP1522-Ab-2; GM-Tg-cang-IP1522-Ab-1/ GM-Tg-cang-IP1522-Ab-2;
GM-Tg-bovg-IP1522-Ab-1/ GM-Tg-bovg-IP1522-Ab-2; GM-Tg-equg-IP1522-Ab-1/ GM-Tg-equg-IP1522-Ab-2
Products NameAnti-RNF19A monoclonal antibody
Formatmab
Target NameRNF19A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RNF19A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1522-Ag-1Recombinant multi-species RN19A/ RNF19A/ RNF19 protein


    Target information

    Target IDGM-IP1522
    Target NameRNF19A
    Gene ID25897,30945,362900,705118,475049,101097376,540195,100055939
    Gene Symbol and SynonymsDorfin,RNF19,RNF19A,Ubce7ip2,UIP117,XYbp
    Uniprot AccessionQ9NV58
    Uniprot Entry NameRN19A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000034677
    Target ClassificationN/A

    The target: RNF19A, gene name: RNF19A, also named as RNF19. This gene encodes a member of the ring between ring fingers (RBR) protein family, and the encoded protein contains two RING-finger motifs and an in between RING fingers motif. This protein is an E3 ubiquitin ligase that is localized to Lewy bodies, and ubiquitylates synphilin-1, which is an interacting protein of alpha synuclein in neurons. The encoded protein may be involved in amyotrophic lateral sclerosis and Parkinson's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.